NewBiologix SA

Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines. NewBiologix is committed to improve the generation and production of viral vectors used in gene and cell therapies by combining innovative and proprietary bioinformatics platform with advanced R&D experimentation. NewBiologix is poised to help partners address an array of rare, chronic, and incurable diseases by filling the innovation gap to meet the surging demand for economically viable, large-scale production of viral vectors for gene therapy.